Retinal layer response to ranibizumab during treatment of diabetic macular edema

Retina

Volumn 36, Issue 7, 2016, Pages 1314-1323

  Ebneter, Andreas ^a   Wolf, Sebastian ^a   Abhishek, Jain ^a   Zinkernagel, Martin S ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

anti VEGF; diabetic macular edema; layer segmentation; optical coherence tomography; predictive; prognostic; ranibizumab; regression analysis; retina

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CASE STUDY; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT RESPONSE; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA;

ANGIOGENESIS INHIBITORS; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RANIBIZUMAB; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84953226934     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000923     Document Type: Article

References (38)

1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-485.
2. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004; 140:945-950.
3. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial Diabetes 1995;44:968-983
4. Wallow IH, Engerman RL. Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol Vis Sci 1977;16:447-461.
5. Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-1371.
6. Ebneter A, Wolf S, Zinkernagel MS. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab. Br J Ophthalmol In press.
7. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370.
8. Brown DM, Nguyen QD, Marcus DM, et al. Long-Term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 2013;120:2013-2022.
9. Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 2014;121:1045-1053.
10. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399-2405.
11. Sivaprasad S, Crosby-Nwaobi R, Esposti SD, et al. Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4). PLoS One 2013;8: e72755.
12. Byeon SH, Chu YK, Hong YT, et al. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tonography. Retina 2012;32: 1087-1099.
13. Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol 2015;159:85-91.
14. Byeon SH, Chu YK, Lee H, et al. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Ophthalmology 2009;116:1949-1959.
15. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1995;113:1144-1155.
16. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-625.
17. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381.
18. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.R-project.org/. Accessed August 23, 2015.
19. Venables WN, Ripley BD. Modern Applied Statistics with S. Fourth Edition. New York, NY: Springer, 2002.
20. Taiyun W. Corrplot: Visualization of a Correlation Matrix. R package version 0.73. Available at: http://CRAN.R-project. org/package-corrplot. Accessed November 12, 2014.
21. Ozaki H, Hayashi H, Vinores SA, et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 1997;64:505-517.
22. Casson RJ, Chidlow G, Ebneter A, et al. Translational neuroprotection research in glaucoma: a review of definitions and principles. Clin Exp Ophthalmol 2012;40:350-357.
23. Tan PE, Yu PK, Balaratnasingam C, et al. Quantitative confocal imaging of the retinal microvasculature in the human retina. Invest Ophthalmol Vis Sci 2012;53:5728-5736.
24. Lange CA, Bainbridge JW. Oxygen sensing in retinal health and disease. Ophthalmologica 2012;227:115-131.
25. Linsenmeier RA. Electrophysiological consequences of retinal hypoxia. Graefes Arch Clin Exp Ophthalmol 1990; 228:143-150.
26. Holfort SK, Klemp K, Kofoed PK, et al. Scotopic electrophysiology of the retina during transient hyperglycemia in type 2 diabetes. Invest Ophthalmol Vis Sci 2010;51:2790-2794.
27. Nguyen QD, Shah SM, Van Anden E, et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004;45:617-624.
28. Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated bloodretinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001;42:2408-2413.
29. Dooley I, Treacy M, O'Rourke M, et al. Serial spectral domain ocular coherence tomography measurement of outer nuclear layer thickness in rhegmatogenous retinal detachment repair. Curr Eye Res 2015;40:1073-1076.
30. Menke MN, Kowal JH, Dufour P, et al. Retinal layer measurements after successful macula-off retinal detachment repair using optical coherence tomography. Invest Ophthalmol Vis Sci 2014;55:6575-6579.
31. Demirkaya N, van Dijk HW, van Schuppen SM, et al. Effect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:4934-4940.
32. Ehnes A, Wenner Y, Friedburg C, et al. Optical coherence tomography (OCT) device independent intraretinal layer segmentation. Transl Vis Sci Technol 2014;3:1.
33. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791.
34. Kern TS, Berkowitz BA. Photoreceptors in diabetic retinopathy. J Diabetes Investig 2015;6:371-380.
35. Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 2015;372:1193-1203.
36. Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005;139:18-29.
37. Lammer J, Scholda C, Prunte C, et al. Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems. Retina 2011; 31:48-55.
38. Waldstein SM, Gerendas BS, Montuoro A, et al. Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments. Br J Ophthalmol 2015;99:794-800.